Suchergebnisse - "Tan, Hooi-Kuan"

PubPharm (18)

1

Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis : an observational prospective cohort study

enthalten in: PLoS medicine | 2010

von Cortina-Borja, M. | Tan, H. | Wallon, M. | +54

2

Recovery of anti-Toxoplasma gondii immunoglobulin M in stored guthrie card blood spots

enthalten in: Journal of clinical microbiology | 2009

von Tan, H. | Petersen, E. | Møller, L. | +3

3

Recovery of Anti-Toxoplasma gondii Immunoglobulin M in Stored Guthrie Card Blood Spots

enthalten in: Journal of clinical microbiology | 2009

von Tan, H. | Petersen, E. | Møller, L. | +3

4

Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe

enthalten in: PLoS neglected tropical diseases | 2008

von Gilbert, R. | Freeman, K. | Lago, E. | +53

5

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis

enthalten in: PloS one | 2008

von Jamieson, S. | de Roubaix, L. | Cortina-Borja, M. | +26

6

Predictors of retinochoroiditis in children with congenital toxoplasmosis : European, prospective cohort study

enthalten in: Pediatrics | 2008

von Freeman, K. | Tan, H. | Prusa, A. | +46

7

Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2008

von Bénard, A. | Petersen, E. | Salamon, R. | +76

8

Supplementation with antioxidants and folinic acid for children with Down's syndrome : randomised controlled trial

enthalten in: BMJ (Clinical research ed.) | 2008

von Ellis, J. | Tan, H. | Gilbert, R. | +10

CommentIn: BMJ. 2008 Mar 15;336(7644):568-9. - PMID 18296459

9

Inequalities in provision of the Disability Living Allowance for Down syndrome

enthalten in: Archives of disease in childhood | 2008

von Ellis, J. | Logan, S. | Pumphrey, R. | +5

CommentIn: Arch Dis Child. 2008 Jan;93(1):1-2. - PMID 18156473

10

RESEARCH - Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial - Daily oral supplementation with antioxidants or folinic acid, or both, or placebo made no difference to infants' biochemical or developmental outcomes up to 18 months later

enthalten in: The BMJ | 2008

von Ellis, J. | Tan, H. | Gilbert, R. | +10